Exploring the impact of menopause on employees in the workplace
Half of the world’s population – approximately 4 billion women – have gone through, are in the process of or will eventually go through menopause. These women also face the challenge of having limited resources and information about menopause and how to manage symptom relief. With the life expectancy for women increasing globally, women will experience the menopausal transition for a significant portion of their lives, with a large percentage experiencing symptoms that are severe and last for many years.1
This white paper explores every aspect of menopause, from symptoms and the treatment landscape to market dynamics and the impact of menopause on employees in the workplace.
Read more
It is widely recognized that further research investment is needed in women’s health in general and in menopause specifically. The White House recently announced that, as part of its Initiative on Women’s Health Research, the Advance Research Projects Agency for Health will be overseeing a $100 million commitment by the government in its Sprint for Women’s Health. This has generated renewed and broader interest in the subject.44
These types of initiatives need to be implemented globally to provide information to women directly, along with their families, communities, physicians and employers, as well as researchers, to develop interventional and other options to support women’s overall well-being at this important stage of their lives.
A strong CRO partner — like the PPD™ clinical research business of Thermo Fisher Scientific— empowers drug developers with the end-to-end solutions and capabilities they need to focus on developing a wider range of therapies to address the diverse needs of menopausal women and improve women’s quality of life.
